Turner Investments’s Heron Therapeutics HRTX Stock Holding History

Turner Investments’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-45,390	Closed	-$782K	–	277
2016 Q3	$782K	Sell	45,390 -51,180	-53%	-$950K	0.26%	124
2016 Q2	$1.74M	Hold	96,570	–	–	0.55%	59
2016 Q1	$1.83M	Sell	96,570 -9,510	-9%	-$188K	0.5%	68
2015 Q4	$2.83M	Buy	106,080 +17,470	+20%	+$467K	0.59%	63
2015 Q3	$2.16M	Buy	88,610 +33,880	+62%	+$1.13M	0.44%	77
2015 Q2	$1.71M	Sell	54,730 -78,010	-59%	-$1.47M	0.31%	113
2015 Q1	$1.93M	Buy	132,740 +52,660	+66%	+$594K	0.35%	96
2014 Q4	$806K	Sell	80,080 -43,650	-35%	-$356K	0.1%	301
2014 Q3	$1.03M	Buy	123,730 +48,730	+65%	+$454K	0.06%	343
2014 Q2	$924K	Buy	+75,000	New	+$896K	0.04%	385

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Turner Investments's HRTX Position: Q4 2016 in Review

Turner Investments sold out of Heron Therapeutics (HRTX) in Q4 2016, closing a stake of 45,390 shares — an estimated $782K sold.

Turner Investments first reported a position in HRTX in Q2 2014 and held it in 10 quarters. The position peaked at $2.83M in Q4 2015. 99 funds tracked by Wall St. Rank hold HRTX as of Q4 2016.

Turner Investments reported no remaining Heron Therapeutics position as of Q4 2016 after selling out during the quarter.
Turner Investments sold 45,390 Heron Therapeutics shares in Q4 2016, an estimated $782K.
Turner Investments first reported a position in Heron Therapeutics in Q2 2014 and held it in 10 quarters.
Turner Investments's Heron Therapeutics position peaked at $2.83M in Q4 2015.
99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.